ATE413872T1 - Verfahren zur behandlung von inkontinenz - Google Patents

Verfahren zur behandlung von inkontinenz

Info

Publication number: ATE413872T1
Authority: AT; Austria
Prior art keywords: treating incontinence; incontinence; treating; gamma; instant invention
Prior art date: 1999-04-08

Application number

AT00905786T

Other languages

English (en)

Inventor

Catherine Segal

Leslie Magnus

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-08

Filing date

2000-01-27

Publication date

2008-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22434891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE413872(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-01-27 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2008-11-15 Application granted granted Critical

2008-11-15 Publication of ATE413872T1 publication Critical patent/ATE413872T1/de

Links

206010021639 Incontinence Diseases 0.000 title abstract 2
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 1
229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Seeds, Soups, And Other Foods (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Saccharide Compounds (AREA)

AT00905786T 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz ATE413872T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12834799P	1999-04-08	1999-04-08

Publications (1)

Publication Number	Publication Date
ATE413872T1 true ATE413872T1 (de)	2008-11-15

Family

ID=22434891

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT00905786T ATE413872T1 (de)	1999-04-08	2000-01-27	Verfahren zur behandlung von inkontinenz
AT08160836T ATE463242T1 (de)	1999-04-08	2000-01-27	Behandlung von inkontinenz

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT08160836T ATE463242T1 (de)	1999-04-08	2000-01-27	Behandlung von inkontinenz

Country Status (13)

Country	Link
EP (2)	EP1977745B1 (de)
JP (1)	JP2002541198A (de)
KR (1)	KR20010103053A (de)
AT (2)	ATE413872T1 (de)
AU (2)	AU779262B2 (de)
CA (1)	CA2362026A1 (de)
DE (2)	DE60044160D1 (de)
ES (2)	ES2313880T3 (de)
HU (1)	HUP0200738A3 (de)
IL (1)	IL145763A0 (de)
TR (1)	TR200102837T2 (de)
WO (1)	WO2000061135A1 (de)
ZA (1)	ZA200107425B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003088335A (ja) *	2001-09-14	2003-03-25	Pharmafoods Kenkyusho:Kk	排尿機能改善用食品組成物及びそれを含有する飲食品
CA2451267A1 (en)	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
DE60332387D1 (de) *	2002-12-13	2010-06-10	Warner Lambert Co	Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege
EP1621193A3 (de) *	2002-12-20	2006-08-02	Dynogen Pharmaceuticals Inc.	Behandlung nicht-schmerzhafter Blasenstörungen mit Kalziumkanalmodulatoren der alpha2-delta-Untereinheit
DE60315258T2 (de) *	2002-12-20	2008-05-08	Dynogen Pharmaceuticals Inc., Waltham	Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
EP1492519B1 (de) *	2003-03-21	2006-11-15	Dynogen Pharmaceuticals, Inc.	Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
KR20060119971A (ko) *	2003-09-11	2006-11-24	제노포트 인코포레이티드	Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
MXPA06004088A (es)	2003-10-14	2006-06-27	Xenoport Inc	Forma cristalina de un analogo del acido gamma-aminobutirico.
ATE511860T1 (de) *	2006-12-22	2011-06-15	Recordati Ireland Ltd	Kombinationstherapie für erkrankungen der unteren harnwege mit 2 liganden und nsar
WO2009087682A2 (en) *	2007-12-28	2009-07-16	Intas Pharmaceuticals Limited	Stabilized injectable formulation of pregabalin
WO2009094577A2 (en)	2008-01-25	2009-07-30	Xenoport, Inc.	Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US7872046B2 (en)	2008-01-25	2011-01-18	Xenoport, Inc.	Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
EP2250143B1 (de)	2008-01-25	2016-04-20	XenoPort, Inc.	Verfahren zur enzymatischen kinetischen racematspaltung von für die synthese von acyloxyalkylcarbamaten verwendeten acyloxyalkylthiocarbonaten
ES2423254B1 (es) *	2012-02-15	2014-03-26	Laboratec, S.L.	Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU9137091A (en) *	1990-11-27	1992-06-25	Northwestern University	Gaba and l-glutamic acid analogs for antiseizure treatment
RU94046105A (ru) *	1992-05-20	1997-06-20	Нортвестерн Юниверсити (Us)	АНАЛОГИ γ -АМИНОМАСЛЯНОЙ КИСЛОТЫ И L-ГЛУТАМИНОВОЙ КИСЛОТЫ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
IT1288123B1 (it) *	1996-09-04	1998-09-10	Nicox Sa	Uso di nitroderivati per l'incontinenza urinaria
US20020045742A1 (en) *	1998-12-15	2002-04-18	Kenneth A. Jones	Dna encoding a gaba b r2 polypeptide and uses thereof

2000
- 2000-01-27 ES ES00905786T patent/ES2313880T3/es not_active Expired - Lifetime
- 2000-01-27 KR KR1020017012748A patent/KR20010103053A/ko not_active Ceased
- 2000-01-27 DE DE60044160T patent/DE60044160D1/de not_active Expired - Lifetime
- 2000-01-27 TR TR2001/02837T patent/TR200102837T2/xx unknown
- 2000-01-27 HU HU0200738A patent/HUP0200738A3/hu unknown
- 2000-01-27 CA CA002362026A patent/CA2362026A1/en not_active Abandoned
- 2000-01-27 AT AT00905786T patent/ATE413872T1/de not_active IP Right Cessation
- 2000-01-27 AT AT08160836T patent/ATE463242T1/de not_active IP Right Cessation
- 2000-01-27 WO PCT/US2000/002141 patent/WO2000061135A1/en not_active Ceased
- 2000-01-27 AU AU27416/00A patent/AU779262B2/en not_active Ceased
- 2000-01-27 EP EP08160836A patent/EP1977745B1/de not_active Expired - Lifetime
- 2000-01-27 ES ES08160836T patent/ES2341059T3/es not_active Expired - Lifetime
- 2000-01-27 EP EP00905786A patent/EP1171114B1/de not_active Expired - Lifetime
- 2000-01-27 DE DE60040784T patent/DE60040784D1/de not_active Expired - Lifetime
- 2000-01-27 IL IL14576300A patent/IL145763A0/xx not_active IP Right Cessation
- 2000-01-27 JP JP2000610468A patent/JP2002541198A/ja active Pending
2001
- 2001-09-07 ZA ZA200107425A patent/ZA200107425B/xx unknown
2005
- 2005-02-11 AU AU2005200619A patent/AU2005200619A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200107425B (en)	2003-02-26
AU779262C (en)	2000-11-14
EP1171114A1 (de)	2002-01-16
KR20010103053A (ko)	2001-11-17
DE60040784D1 (de)	2008-12-24
TR200102837T2 (tr)	2002-03-21
IL145763A0 (en)	2002-07-25
ES2341059T3 (es)	2010-06-14
ES2313880T3 (es)	2009-03-16
ATE463242T1 (de)	2010-04-15
WO2000061135A1 (en)	2000-10-19
DE60044160D1 (de)	2010-05-20
EP1977745A1 (de)	2008-10-08
AU779262B2 (en)	2005-01-13
HUP0200738A3 (en)	2003-03-28
AU2741600A (en)	2000-11-14
AU2005200619A1 (en)	2005-03-10
HUP0200738A2 (hu)	2002-07-29
CA2362026A1 (en)	2000-10-19
EP1977745B1 (de)	2010-04-07
JP2002541198A (ja)	2002-12-03
EP1171114B1 (de)	2008-11-12

Legal Events

Date	Code	Title	Description
2009-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60040784D1 (de)	2008-12-24	Verfahren zur behandlung von inkontinenz
DE69535498D1 (de)	2007-06-28	Verfahren zur behandlung vaskulärer kopfschmerzen
DE69319270D1 (de)	1998-07-30	Verfahren zur Behandlung von organischen Schlämmen
DE69729946D1 (de)	2004-08-26	Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
WO2000002546A3 (en)	2000-06-15	Use of caba-analogues for treating insomnia
DE59807122D1 (de)	2003-03-13	Verwendung von fumarsäurederivaten zur behandlung von autoimmunerkrankungen
DE60025369D1 (de)	2006-03-30	Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
ATE259245T1 (de)	2004-02-15	Verfahren zur behandlung von beweggungsstörungen
ATE250066T1 (de)	2003-10-15	Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE60122532D1 (de)	2006-10-05	Verfahren zur behandlung von mehreren bohrlochintervallen
DE69735778D1 (de)	2006-06-01	Verfahren zur Behandlung von rostfreien Stahlschlacken
DE60023872D1 (de)	2005-12-15	Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
ATE331527T1 (de)	2006-07-15	Verfahren zur behandlung von brustdrüsenerkrankungen
DE69129115D1 (de)	1998-04-23	Neues verfahren zur behandlung von depression
DE60212613D1 (de)	2006-08-03	Doxycyclin zur behandlung von akne
DE60106178D1 (de)	2004-11-11	Verfahren zur Isolierung von hochgereinigten ungesättigten Fettsäuren mittels Kristallisation
ATA17552001A (de)	2003-05-15	Verfahren zur behandlung säurehältiger abwässer
DE60035326D1 (de)	2007-08-09	Verfahren zur Behandlung von Abwasser
PL344580A1 (en)	2001-11-05	Aza-heterocyclic compounds used to treat neurological disorders and hair loss
DE59209268D1 (de)	1998-05-07	Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
ATE368110T1 (de)	2007-08-15	Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
EP1200538A4 (de)	2003-04-16	Verfahren zur behandlung von petroleumsäuren
DE59908511D1 (de)	2004-03-18	Verfahren zur peroxidischen Behandlung von Olefinpolymerisaten
DE69524479D1 (de)	2002-01-24	Verfahren zur Behandlung von sauren Abgasen
DE69736180D1 (de)	2006-08-03	Behandlung von manischen erkrankungen